4-2271411-G-C
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PM2PP3
The NM_020972.3(ZFYVE28):āc.2432C>Gā(p.Pro811Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000098 in 1,612,676 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.00012 ( 1 hom., cov: 33)
Exomes š: 0.000096 ( 0 hom. )
Consequence
ZFYVE28
NM_020972.3 missense
NM_020972.3 missense
Scores
6
9
4
Clinical Significance
Conservation
PhyloP100: 9.22
Genes affected
ZFYVE28 (HGNC:29334): (zinc finger FYVE-type containing 28) Enables phosphatidylinositol-3-phosphate binding activity. Involved in negative regulation of epidermal growth factor-activated receptor activity. Located in cytosol and early endosome membrane. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 3 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.808
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZFYVE28 | NM_020972.3 | c.2432C>G | p.Pro811Arg | missense_variant | 12/13 | ENST00000290974.7 | NP_066023.2 | |
ZFYVE28 | NM_001172656.2 | c.2342C>G | p.Pro781Arg | missense_variant | 11/12 | NP_001166127.1 | ||
ZFYVE28 | NM_001172659.2 | c.2222C>G | p.Pro741Arg | missense_variant | 12/13 | NP_001166130.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZFYVE28 | ENST00000290974.7 | c.2432C>G | p.Pro811Arg | missense_variant | 12/13 | 1 | NM_020972.3 | ENSP00000290974 | P2 |
Frequencies
GnomAD3 genomes AF: 0.000118 AC: 18AN: 152258Hom.: 1 Cov.: 33
GnomAD3 genomes
AF:
AC:
18
AN:
152258
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000648 AC: 16AN: 246796Hom.: 0 AF XY: 0.0000968 AC XY: 13AN XY: 134274
GnomAD3 exomes
AF:
AC:
16
AN:
246796
Hom.:
AF XY:
AC XY:
13
AN XY:
134274
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000959 AC: 140AN: 1460300Hom.: 0 Cov.: 31 AF XY: 0.0000950 AC XY: 69AN XY: 726438
GnomAD4 exome
AF:
AC:
140
AN:
1460300
Hom.:
Cov.:
31
AF XY:
AC XY:
69
AN XY:
726438
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000118 AC: 18AN: 152376Hom.: 1 Cov.: 33 AF XY: 0.0000671 AC XY: 5AN XY: 74506
GnomAD4 genome
AF:
AC:
18
AN:
152376
Hom.:
Cov.:
33
AF XY:
AC XY:
5
AN XY:
74506
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
0
ALSPAC
AF:
AC:
2
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
1
ExAC
AF:
AC:
9
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 16, 2024 | The c.2432C>G (p.P811R) alteration is located in exon 12 (coding exon 12) of the ZFYVE28 gene. This alteration results from a C to G substitution at nucleotide position 2432, causing the proline (P) at amino acid position 811 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Uncertain
T
BayesDel_noAF
Uncertain
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Benign
T;T;.;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D;D;D;D
M_CAP
Pathogenic
D
MetaRNN
Pathogenic
D;D;D;D
MetaSVM
Uncertain
D
MutationAssessor
Pathogenic
.;M;.;.
MutationTaster
Benign
D;D;D;D
PrimateAI
Uncertain
T
PROVEAN
Pathogenic
D;D;D;D
REVEL
Uncertain
Sift
Benign
D;D;D;D
Sift4G
Benign
T;D;D;D
Polyphen
1.0, 0.79
.;D;P;.
Vest4
MVP
MPC
0.29
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at